Status:
RECRUITING
Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
Lead Sponsor:
Montreal Heart Institute
Conditions:
Infective Endocarditis
Native Valve Endocarditis
Eligibility:
All Genders
18+ years
Brief Summary
The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria...
Eligibility Criteria
Inclusion
- 18 years of age or older, capable to provide informed consent;
- Referred for a FDG-PET/CT study
- Classified as having Possible IE prior to FDG-PET/CT imaging;
- Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan.
Exclusion
- Subjects with prosthetic cardiac valve and/or CIED;
- Pregnant or breastfeeding female;
- Body mass index \> 45 kg/m2.
Key Trial Info
Start Date :
August 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04792281
Start Date
August 31 2021
End Date
December 31 2025
Last Update
November 22 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Universite de Montreal
Montreal, Quebec, Canada, H2X 3E4
2
Montreal Heart Institute
Montreal, Quebec, Canada, H3l 3c1
3
Jewish General Hospital
Montreal, Quebec, Canada, H3T 1E2
4
McGill University Health Center
Montreal, Quebec, Canada, H4A 3J1